TheracosBio Email Format

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

TheracosBio is a small- to mid-sized pharmaceutical company based in Framingham, Massachusetts, that focuses on discovering, developing, and commercializing medicines for significant diseases. It aligns its strategy with the goal of making affordable medications for prevalent conditions to advance public health. Its portfolio includes Brenzavvy (bexagliflozin), an FDA-approved therapy for diabetes.

The company serves providers and patients seeking access to approved treatments for chronic conditions. In September 2025, TheracosBio announced a partnership with Wellgistics Health to broaden Brenzavvy’s reach, extending access through more than 6,500 pharmacies nationwide.

Sign up for free to view info

Company overview Employee directory